Cholesterol efflux capacity as an indicator of HDL dysfunction across the metabolic syndrome spectrum in a South Indian cohort

Abstract Background:To evaluate high density lipoprotein(HDL) functionality using cholesterol efflux capacity(CEC) across control, pre-metabolic syndrome(PreMetS) and metabolic syndrome(MetS) groups in a South Indian cohort and determine its association with metabolic parameters and disease severity. Methods:This cross-sectional study included 88 adults [Control (n = 38; age 32.9 ± 6.20 years; M:F 19:19), Pre-MetS (n = 24; age 36.5 ± 3.50 years; M:F 15:9), MetS (n = 26; age 46.6 ± 5.68 years; M:F 17:9)] classified using modified NCEP ATP III criteria. Anthropometric (BMI, waist circumference, blood pressure) and biochemical parameters (fasting glucose, triglycerides, HDL-C, LDL-C, ApoA1, insulin, HOMA-IR) were assessed using standardised protocols. HDL functionality was measured via BODIPY-cholesterol efflux in PMA-differentiated THP-1 macrophages. Multiple linear regression and Spearman correlations were performed (p < 0.05). Results:Progressive intergroup differences were observed in waist circumference, BMI, fasting glucose, insulin, triglycerides, and HOMA-IR (p < 0.001). ApoA1 declined proportionally across groups (231 vs 206 vs 187 ng/mL; ε 2 = 0.839, p < 0.001), representing the largest effect size in the dataset. Notably, CEC considerably reduced at the Pre-MetS stage and remained diminished with progressive metabolic deterioration, emphasizing early detection and intervention. CEC differed significantly across the metabolic spectrum (p < 0.001). Multiple linear regression identified triglycerides and insulin resistance as independent negative predictors of CEC, adjusting for HDL-C and ApoA1 (adjusted R 2 = 0.769). Conclusion:CEC is significantly diminished at the Pre-MetS stage and remains reduced with progressive metabolic deterioration. Triglyceride enrichment and insulin-mediated suppression of ApoA1 synthesis likely impair HDL remodelling and efflux capacity. These findings highlight CEC as an indicator of HDL dysfunction with implications for earlier cardiometabolic risk assessment in South Indian populations.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-78277-9
Primary Topic
Cholesterol and Lipid Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cholesterol efflux capacity as an indicator of HDL dysfunction across the metabolic syndrome spectrum in a South Indian cohort

Rukmini Mysore Srikantiah, Guruprasad Kanive Parashiva, Sindhu Harish, Swathi Maruthiyodan et al.
1 links
Scientific Reports
Cholesterol and Lipid Metabolism
article

Cholesterol efflux capacity as an indicator of HDL dysfunction across the metabolic syndrome spectrum in a South Indian cohort

Rukmini Mysore Srikantiah, Guruprasad Kanive Parashiva, Sindhu Harish, Swathi Maruthiyodan, Anand K. Rohatgi, Anupama Hegde, Arun Shirali, Anita Sherly A
article en

Abstract

Abstract Background:To evaluate high density lipoprotein(HDL) functionality using cholesterol efflux capacity(CEC) across control, pre-metabolic syndrome(PreMetS) and metabolic syndrome(MetS) groups in a South Indian cohort and determine its association with metabolic parameters and disease severity. Methods:This cross-sectional study included 88 adults [Control (n = 38; age 32.9 ± 6.20 years; M:F 19:19), Pre-MetS (n = 24; age 36.5 ± 3.50 years; M:F 15:9), MetS (n = 26; age 46.6 ± 5.68 years; M:F 17:9)] classified using modified NCEP ATP III criteria. Anthropometric (BMI, waist circumference, blood pressure) and biochemical parameters (fasting glucose, triglycerides, HDL-C, LDL-C, ApoA1, insulin, HOMA-IR) were assessed using standardised protocols. HDL functionality was measured via BODIPY-cholesterol efflux in PMA-differentiated THP-1 macrophages. Multiple linear regression and Spearman correlations were performed (p < 0.05). Results:Progressive intergroup differences were observed in waist circumference, BMI, fasting glucose, insulin, triglycerides, and HOMA-IR (p < 0.001). ApoA1 declined proportionally across groups (231 vs 206 vs 187 ng/mL; ε 2 = 0.839, p < 0.001), representing the largest effect size in the dataset. Notably, CEC considerably reduced at the Pre-MetS stage and remained diminished with progressive metabolic deterioration, emphasizing early detection and intervention. CEC differed significantly across the metabolic spectrum (p < 0.001). Multiple linear regression identified triglycerides and insulin resistance as independent negative predictors of CEC, adjusting for HDL-C and ApoA1 (adjusted R 2 = 0.769). Conclusion:CEC is significantly diminished at the Pre-MetS stage and remains reduced with progressive metabolic deterioration. Triglyceride enrichment and insulin-mediated suppression of ApoA1 synthesis likely impair HDL remodelling and efflux capacity. These findings highlight CEC as an indicator of HDL dysfunction with implications for earlier cardiometabolic risk assessment in South Indian populations.

Scientific Reports
Manipal Academy of Higher Education (IN), Kasturba Medical College, Mangalore (IN), Kasturba Medical College, Manipal (IN), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon